SCHEMBL5174648

SCHEMBL5174648

N#Cc1ccccc1[C@H](NC(C(N)=O)c1ccccc1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 3/20 0.38
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
PLA2G7 Q13093 1/20 0.35
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
CYP2D6 P10635 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5176805 0.85 FNTA (0.39) MAPTNPSR1ALDH1A1FNTAFNTB
SCHEMBL5127464 0.85 MMP2 (0.37) MAPTNPSR1ALDH1A1GAAKDM4E
SCHEMBL5176838 0.84 CYP2D6 (0.43) MAPTFNTAFNTBCA1CA2
SCHEMBL5177320 0.84 FLT1 (0.40) NPSR1ALDH1A1GAAFNTAFNTB
SCHEMBL5175656 0.81 CNR2 (0.44) MAPTNPSR1ALDH1A1KDM4EFNTA
SCHEMBL5176187 0.79 FNTA (0.39) MAPTNPSR1ALDH1A1GAAGLA
SCHEMBL5175956 0.79 FLT1 (0.40) ALDH1A1GAAFNTAFNTBCA1
SCHEMBL5236529 0.78 AVPR2 (0.40) FNTAFNTB
SCHEMBL5186094 0.78 SLC6A9 (0.40) MAPTALDH1A1FNTAFNTBPSEN1
SCHEMBL5186098 0.78 SLC6A9 (0.40) MAPTALDH1A1FNTAFNTBPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747195-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Pfizer Products Incorporated (US) 2007-01-31 EP claimed
WO-2005095334-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER PRODUCTS INC. (US) 2005-10-13 WO claimed